Answer
Its licence is for additional cardiovascular-risk reduction in eligible adults already treated with a statin, rather than as a replacement.
Sources for this answer
- Vazkepa — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.